What is the recommended prophylaxis regimen for scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Scabies Prophylaxis

For close contacts of scabies patients, prophylactic treatment with permethrin 5% cream (applied neck-down for 8-14 hours) OR oral ivermectin 200 mcg/kg (repeated in 2 weeks) is recommended, even if asymptomatic. 1

Who Requires Prophylaxis

All persons with sexual, close personal, or household contact within the preceding month should be examined and treated prophylactically 1. This includes:

  • Sexual partners
  • Household members
  • Close personal contacts with prolonged skin-to-skin contact
  • Healthcare workers in outbreak settings

The rationale is critical: scabies has a 4-6 week incubation period before symptoms develop 2. During this asymptomatic phase, infected contacts actively transmit the mite to others, making prophylactic treatment essential to break the transmission chain.

Recommended Prophylactic Regimens

First-Line Options

Permethrin 5% cream:

  • Apply to all body areas from neck down
  • Wash off after 8-14 hours
  • Repeat application in 1 week
  • Most effective, safe, and less expensive than ivermectin 1

Oral ivermectin:

  • 200 mcg/kg single dose
  • Must repeat in 2 weeks (limited ovicidal activity requires second dose to kill newly hatched mites) 1
  • Take with food to increase bioavailability and epidermal penetration 1
  • Particularly useful in institutional outbreaks 1, 3

Special Populations

Infants and young children:

  • Use permethrin only 1
  • Ivermectin safety not established in children <15 kg 1

Pregnant/lactating women:

  • Permethrin is preferred 1
  • Ivermectin classified as "low risk" but limited data 1

Children <10 years:

  • Never use lindane (neurotoxicity risk) 1

Institutional Outbreak Management

In nursing homes, hospitals, or residential facilities, treat the entire population at risk simultaneously 1, 4. Control requires:

  • Mass treatment of all residents and staff (even asymptomatic)
  • Ivermectin particularly useful when topical scabicides fail 1
  • Single-dose ivermectin 200 mcg/kg effective for mass prophylaxis 3, 5
  • Consultation with specialist recommended 1

Critical success factor: One study in a prison setting showed prophylaxis with ivermectin 300 mcg/kg (repeated after 7 days) was 93.2% effective in preventing infection in non-infected inmates 3.

Environmental Decontamination (Essential Component)

Prophylaxis fails without proper decontamination:

  • Machine-wash and machine-dry bedding/clothing using hot cycle, OR
  • Dry clean, OR
  • Remove from body contact for at least 72 hours 1
  • Fumigation is unnecessary 1

The scabies mite survives off human skin for up to 4 days 6, making this 72-hour isolation period critical.

Common Pitfalls

Incomplete contact treatment: The most frequent cause of prophylaxis failure is not treating all household and close contacts simultaneously 1. Studies show only 32% of patients had contacts treated appropriately 7, and most GPs treat fewer contact categories than recommended 7.

Single-dose ivermectin: Remember that ivermectin has limited ovicidal activity—the second dose at 2 weeks is mandatory, not optional 1.

Timing confusion: Pruritus and rash can persist up to 2 weeks after successful treatment due to allergic dermatitis 1. This is NOT treatment failure and does not require retreatment unless live mites are observed.

Lindane use: This should be avoided for prophylaxis due to neurotoxicity risks (seizures, aplastic anemia) and is only for treatment failures when other options are not tolerated 1.

Evidence Quality Note

The CDC STD Treatment Guidelines (2015) 1 provide the strongest guideline-level evidence. However, a 2014 Cochrane review 2 found no RCTs specifically evaluating prophylactic interventions for contacts—all existing trials combined contact and index case data. Despite this evidence gap, prophylactic treatment remains standard practice based on the mite's biology, transmission patterns, and observational data from outbreak control 3, 8.

The European guideline recommends a 2-month look-back period for partner management 5, which is more conservative than the CDC's 1-month recommendation but may be more appropriate given the prolonged incubation period.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.